A systems approach identifies time-dependent associations of multimorbidities with pancreatic cancer risk

Annals of Oncology

Volumn 28, Issue 7, 2017, Pages 1618-1624

  Gomez Rubio, P ^a   Rosato, V ^b,c   Marquez M ^a   Bosetti, C ^d   Molina Montes, E ^a   Rava, M ^a   Pinero J ^e   Michalski, C W ^f,g   Farre A ^h   Molero, X ^i,j,k   Lohr M ^l   Ilzarbe, L ^m   Perea, J ⁿ   Greenhalf, W ^o   O'Rorke, M ^p   Tardon A ^k,q   Gress, T ^r   Barbera V M ^s   Crnogorac Jurcevic, T ^t   Munoz Bellvis L ^u   Dominguez Munoz E ^v   Gutierrez Sacristan A ^e   Balsells, J ^i,j,k   Costello, E ^o   Guillen Ponce C ^w   Huang, J ^l   Iglesias, M ^m   Kleeff, J ^f,o   Kong, B ^f   Mora, J ^h   Murray, L ^p   O'Driscoll, D ^x   Pelaez P ⁿ   Poves, I ^m   Lawlor, R T ^y   Carrato, A ^w   Hidalgo, M ^z   Scarpa, A ^y   Sharp, L ^x,aa   Furlong, L I ^e   Real, F X ^e,ab   La Vecchia, C ^b   Malats, N ^a   more..

^a Autonomous University of Madrid Instituto de Investigación Hospital Universitario La Paz   (United States)

^b UNIVERSITY OF MILAN   (Italy)

^c NATIONAL CANCER INSTITUTE   (Italy)

^d MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^e UNIVERSITAT POMPEU FABRA   (Spain)

^f TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^g UNIVERSITY OF HEIDELBERG   (Germany)

^h HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

ⁱ HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^j UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^k INSTITUTO DE SALUD CARLOS III   (Spain)

^l KAROLINSKA INSTITUTE   (Sweden)

^m Parc de Salut Mar   (Spain)

ⁿ HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^o ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^p QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^q DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^r UNIVERSITY HOSPITAL MARBURG   (Germany)

^s HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

^t QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^u UNIVERSITY OF SALAMANCA   (Spain)

^v University Hospital of Santiago de Compostela   (Spain)

^w HOSPITAL RAMÓN Y CAJAL   (Spain)

^x NATIONAL CANCER REGISTRY IRELAND   (Ireland)

^y UNIVERSITY AND HOSPITAL TRUST OF VERONA   (Italy)

^z Department of Radiation Oncology Hospital San Chinarro   (Spain)

^aa NEWCASTLE UNIVERSITY   (United Kingdom)

^ab Structural Biology and Biocomputing Programme

more..

Author keywords

multimorbidity; pancreatic cancer; risk

Indexed keywords

TUMOR MARKER;

BIOLOGY; CASE CONTROL STUDY; CLUSTER ANALYSIS; COMORBIDITY; EUROPE; FACTOR ANALYSIS; GENETIC DATABASE; GENETICS; HUMAN; MULTIVARIATE ANALYSIS; ODDS RATIO; PANCREAS CARCINOMA; PANCREAS TUMOR; PRINCIPAL COMPONENT ANALYSIS; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; SYSTEM ANALYSIS; SYSTEMS BIOLOGY; TIME FACTOR;

BIOMARKERS, TUMOR; CARCINOMA, PANCREATIC DUCTAL; CASE-CONTROL STUDIES; CLUSTER ANALYSIS; COMORBIDITY; COMPUTATIONAL BIOLOGY; DATABASES, GENETIC; EUROPE; FACTOR ANALYSIS, STATISTICAL; HUMANS; LOGISTIC MODELS; MULTIVARIATE ANALYSIS; ODDS RATIO; PANCREATIC NEOPLASMS; PRINCIPAL COMPONENT ANALYSIS; RISK ASSESSMENT; RISK FACTORS; SYSTEMS ANALYSIS; SYSTEMS BIOLOGY; TIME FACTORS;

EID: 85029187330     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdx167     Document Type: Article

References (26)

1. Olson, SH., Selected medical conditions and risk of pancreatic cancer. Mol Carcinog 51:1 (2012), 75–97.
2. Ko, A.H., Wang, F., Holly, E.A., Pancreatic cancer and medical history in a population-based case-control study in the San Francisco Bay Area, California. Cancer Causes Control 18:8 (2007), 809–819.
3. Raimondi, S., Lowenfels, A.B., Morselli-Labate, A.M., et al. Pancreatic cancer in chronic pancreatitis; aetiology, incidence, and early detection. Best Pract Res Clin Gastroenterol 24:3 (2010), 349–358.
4. Bosetti, C., Rosato, V., Li, D., et al. Diabetes, antidiabetic medications, and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case-Control Consortium. Ann Oncol 25:10 (2014), 2065–2072.
5. Genkinger, J.M., Spiegelman, D., Anderson, K.E., et al. A pooled analysis of 14 cohort studies of anthropometric factors and pancreatic cancer risk. Int J Cancer 129:7 (2011), 1708–1717.
6. Eckel, R.H., Alberti, K., Grundy, S.M., Zimmet, PZ., The metabolic syndrome. Lancet 375:9710 (2010), 181–183.
7. Rosato, V., Tavani, A., Bosetti, C., et al. Metabolic syndrome and pancreatic cancer risk: A case-control study in Italy and meta-analysis. Metab Clin Exp 60:10 (2011), 1372–1378.
8. Russo, A., Autelitano, M., Bisanti, L., Metabolic syndrome and cancer risk. Eur J Cancer 44:2 (2008), 293–297.
9. Inoue, M., Noda, M., Kurahashi, N., et al. Impact of metabolic factors on subsequent cancer risk: results from a large-scale population-based cohort study in Japan. Eur. J. Cancer Prev 18:3 (2009), 240–247.
10. Matthews, C.E., Sui, X., Lamonte, M.J., et al. Metabolic syndrome and risk of death from cancers of the digestive system. Metab Clin Exp 59:8 (2010), 1231–1239.
11. Johansen, D., Stocks, T., Jonsson, H., et al. Metabolic factors and the risk of pancreatic cancer: a prospective analysis of almost 580,000 men and women in the Metabolic Syndrome and Cancer Project. Cancer. Epidemiol. Biomarkers Prev 19:9 (2010), 2307–2317.
12. Stocks, T., Bjorge, T., Ulmer, H., et al. Metabolic risk score and cancer risk: pooled analysis of seven cohorts. Int. J. Epidemiol, 2015, 1–11.
13. Lipworth, L., Zucchetto, A., Bosetti, C., et al. Diabetes mellitus, other medical conditions and pancreatic cancer: a case-control study. Diabetes Metab Res Rev 27:3 (2011), 255–261.
14. Bosetti, C., Lucenteforte, E., Bracci, P.M., et al. Ulcer, gastric surgery and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case-Control Consortium (PanC4). Ann Oncol 24:11 (2013), 2903–2910.
15. Luo, J., Nordenvall, C., Nyrén, O., et al. The risk of pancreatic cancer in patients with gastric or duodenal ulcer disease. Int J Cancer 120:2 (2007), 368–372.
16. Bao, Y., Spiefelman, D., Li, R., et al. History of peptic ulcer diseases and pancreatic cancer risk in men. Gastroenterology 138:2 (2010), 541–549.
17. Schulte, A., Pandeya, N., Fawcett, J., et al. Association between Helicobacter pylori and pancreatic cancer risk: a meta-analysis. Cancer Causes Control 26:7 (2015), 1027–1035.
18. Holly, E.A., Chaliha, I., Bracci, P.M., Gautam, M., Signs and symptoms of pancreatic cancer: a population-based case-control study in the San Francisco Bay area. Clin Gastroenterol Hepatol 2:6 (2004), 510–517.
19. Batabyal, P., Vander Hoorn, S., Christophi, C., Nikfarjam, M., Association of diabetes mellitus and pancreatic adenocarcinoma: a meta-analysis of 88 studies. Ann Surg Oncol 21:7 (2014), 2453–2462.
20. Cotterchio, M., Lowcock, E., Hudson, T.J., et al. Association between allergies and risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev 23:3 (2014), 469–480.
21. Real, FX., A “catastrophic hypothesis” for pancreas cancer progression. Gastroenterology 124:7 (2003), 1958–1964.
22. Ben, Q., Xu, M., Ning, X., et al. Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studies. Eur J Cancer 47:13 (2011), 1928–1937.
23. Elena, J.W., Steplowski, E., Yu, K., et al. Diabetes and risk of pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. Cancer Causes Control 24:1 (2013), 13–25.
24. Pannala, R., Leirness, J.B., Bamlet, W.R., et al. Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus. Gastroenterology 134:4 (2008), 981–987.
25. Nakamori, S., Ishikawa, O., Ohigashi, H., et al. Increased blood proinsulin and decreased C-peptide levels in patients with pancreatic cancer. Hepatogastroenterology 46:25 (1999), 16–24.
26. Gerdtsson, A.S., Malats, N., Säll, A., et al. A multicenter trial defining a serum protein signature associated with pancreatic ductal adenocarcinoma. Int J Proteomics, 2015, 2015, 587250.